Statutory instrument laid in the House of Lords and House of Commons, on Wednesday, 2 September 2020 by Secretary Elizabeth Truss on behalf of the Department for International Trade. It was approved by the House of Commons on Tuesday, 29 September 2020. It was made on Wednesday, 25 November 2020.

Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations

Secondary information

Type: Statutory instrument
Reference: SI 2020/1354; 2020/
Session: 2019-21
Coming into force: In accordance with regulation 1
Procedure: Affirmative
Laying authority: Act
Laid in draft: Yes
Referred to: DL
Related items: Exiting The European Union (International Trade)
Tuesday, 29 September 2020
Parliamentary proceedings
House of Commons; Draft Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Monday, 28 September 2020
Committee proceedings
House of Commons; Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Tuesday, 10 November 2020
Parliamentary proceedings
House of Lords; Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Tuesday, 17 November 2020
Parliamentary proceedings
House of Lords
Contains explanatory memorandum: Yes
Subjects: Developing countries Drugs Trade
Legislation: European Union (Withdrawal) Act 2018; Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Library location: Commons Library: UP 971 2019-21
Link: View this Statutory instrument on www.legislation.gov.uk